AFC
PFE icon

Ares Financial Consulting’s Pfizer PFE Stock Holding History

Ares Financial Consulting’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Sell
22,342
-43
-0.2% -$1.13K 0.39% 47
2026
Q1 		$639K Buy
22,385
+1,359
+6% +$36.2K 0.5% 36
2025
Q4 		$524K Buy
+21,026
New +$530K 0.5% 43

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Ares Financial Consulting's PFE Position: Q2 2026 in Review

Ares Financial Consulting reduced its Pfizer (PFE) stake by 0.19% in Q2 2026, selling an estimated $1.13K and leaving 22,342 shares worth $538K. The position accounts for 0.39% of the portfolio, ranked #47.

Ares Financial Consulting first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $639K in Q1 2026. 1,599 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ares Financial Consulting held 22,342 shares of Pfizer worth $538K as of Q2 2026.
  • Ares Financial Consulting sold 43 Pfizer shares in Q2 2026, an estimated $1.13K.
  • Pfizer made up 0.39% of Ares Financial Consulting's portfolio in Q2 2026, its #47 holding.
  • Ares Financial Consulting first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Pfizer position peaked at $639K in Q1 2026.
  • 1,599 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.